Home ariad
 

Keywords :   


Tag: ariad

Ariad Pharmaceuticals, Inc. (ARIA) Scheduled to Post Quarterly Earnings on Tuesday

2016-02-22 09:52:14| Biotech - Topix.net

Ariad Pharmaceuticals, Inc. will be releasing its Q415 earnings data on Tuesday, February 23rd. Analysts expect Ariad Pharmaceuticals to post earnings of per share and revenue of $44.79 million for the quarter.

Tags: post tuesday scheduled quarterly

 

Premarket Biotech Digest: Gilead's Upside, Shire-Baxalta Deal, ARIAD Lowers Guidance

2015-12-14 14:57:58| Biotech - Topix.net

I will be looking at some of the big names in the biotech sector over the next two weeks, starting with Gilead Sciences today. Within the large cap growth space in the biotech sector , Gilead continues to be my top pick.

Tags: deal guidance digest biotech

 
 

Ariad shares fall as it cuts revenue guidance

2015-12-12 15:42:31| Biotech - Topix.net

Shares of Ariad Pharmaceuticals fell Friday after it cut revenue guidance as it continues to negotiate with French regulators over the price of its leukemia treatment, Iclusig. The Cambridge, Massachusetts-based developer of cancer treatments said that it previously expected to reach an agreement by the end of the year, but it now expects negotiations to continue into 2016.

Tags: fall revenue shares guidance

 

Ariad Pharmaceuticals Sees Large Decline in Short Interest

2015-12-01 11:52:29| Biotech - Topix.net

Shares of Ariad Pharmaceuticals were the recipient of a significant decline in short interest in the month of November. As of November 13th, there was short interest totalling 30,675,599 shares, a decline of 4.3% from the October 30th total of 32,043,531 shares, AnalystRatings.Net reports.

Tags: large short interest decline

 

a Ariad is at the bottom of a big biotech food chain, at least for now

2015-09-02 03:25:23| Biotech - Topix.net

The wave of merger-mania running through the biotech industry right now appears to be as much about companies trying not to be eaten as it is about companies eager to eat. That's according to Jacob Plieth , a reporter at EP Vantage with whom I interviewed last month regarding the attempt by Shire Pharmaceuticals to acquire newly launched Baxalta .

Tags: for now big least

 

Sites : [1] [2] [3] [4] [5] next »